Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 14, Issue 9, Pages 992-999
Publisher
Wiley
Online
2012-06-28
DOI
10.1093/eurjhf/hfs092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- α-Defensins and outcome in patients with chronic heart failure
- (2012) Heidi M. Christensen et al. EUROPEAN JOURNAL OF HEART FAILURE
- The role of monocytes and inflammation in the pathophysiology of heart failure
- (2011) Benjamin J. Wrigley et al. EUROPEAN JOURNAL OF HEART FAILURE
- C-Reactive Protein
- (2011) Rainer Schulz et al. HYPERTENSION
- Pitavastatin Improves Plasma Pentraxin 3 and Arterial Stiffness in Atherosclerotic Patients with Hypercholesterolemia
- (2011) Hiroyuki Ohbayashi et al. Journal of Atherosclerosis and Thrombosis
- Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction
- (2011) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins Enhance Formation of Phagocyte Extracellular Traps
- (2010) Ohn A. Chow et al. Cell Host & Microbe
- C-reactive protein is a bystander of cardiovascular disease
- (2010) S. S. Anand et al. EUROPEAN HEART JOURNAL
- Regulation of leukocyte recruitment by the long pentraxin PTX3
- (2010) Livija Deban et al. NATURE IMMUNOLOGY
- Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis
- (2010) R. Dubin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
- (2009) Barbara Bottazzi et al. Annual Review of Immunology
- Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause Death
- (2009) Nancy Swords Jenny et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2009) John J.V. McMurray et al. CIRCULATION
- Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
- (2009) Kazumi Yamasaki et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
- (2009) Stephane Heymans et al. EUROPEAN JOURNAL OF HEART FAILURE
- Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure
- (2008) Anca Radauceanu et al. JOURNAL OF CARDIAC FAILURE
- Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic Review
- (2008) José Paulo Araújo et al. JOURNAL OF CARDIAC FAILURE
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
- (2007) Satoshi Suzuki et al. AMERICAN HEART JOURNAL
- Prognostic value of pentraxin 3 in patients with chronic heart failure
- (2007) Norihiko Kotooka et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More